These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29484415)

  • 1. Metformin facilitates BG45‑induced apoptosis via an anti‑Warburg effect in cholangiocarcinoma cells.
    Tang D; Xu L; Zhang M; Dorfman RG; Pan Y; Zhou Q; Zhou L; Wang Y; Li Y; Yin Y; Wang L; Zou X
    Oncol Rep; 2018 Apr; 39(4):1957-1965. PubMed ID: 29484415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition.
    Yin Y; Zhang M; Dorfman RG; Li Y; Zhao Z; Pan Y; Zhou Q; Huang S; Zhao S; Yao Y; Zou X
    Cell Death Dis; 2017 Jun; 8(6):e2856. PubMed ID: 28569784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low levels of pyruvate induced by a positive feedback loop protects cholangiocarcinoma cells from apoptosis.
    Zhang M; Pan Y; Tang D; Dorfman RG; Xu L; Zhou Q; Zhou L; Wang Y; Li Y; Yin Y; Kong B; Friess H; Zhao S; Wu JL; Wang L; Zou X
    Cell Commun Signal; 2019 Mar; 17(1):23. PubMed ID: 30866966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors.
    He JC; Yao W; Wang JM; Schemmer P; Yang Y; Liu Y; Qian YW; Qi WP; Zhang J; Shen Q; Yang T
    Oncotarget; 2016 Nov; 7(46):75441-75456. PubMed ID: 27705912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming.
    Xu L; Wang L; Zhou L; Dorfman RG; Pan Y; Tang D; Wang Y; Yin Y; Jiang C; Zou X; Wu J; Zhang M
    Neoplasia; 2019 May; 21(5):429-441. PubMed ID: 30933885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of metformin on cholangiocarcinoma: In vitro and in vivo studies.
    Fujimori T; Kato K; Fujihara S; Iwama H; Yamashita T; Kobayashi K; Kamada H; Morishita A; Kobara H; Mori H; Okano K; Suzuki Y; Masaki T
    Oncol Rep; 2015 Dec; 34(6):2987-96. PubMed ID: 26398221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT3 elicited an anti-Warburg effect through HIF1α/PDK1/PDHA1 to inhibit cholangiocarcinoma tumorigenesis.
    Xu L; Li Y; Zhou L; Dorfman RG; Liu L; Cai R; Jiang C; Tang D; Wang Y; Zou X; Wang L; Zhang M
    Cancer Med; 2019 May; 8(5):2380-2391. PubMed ID: 30993888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway.
    Wandee J; Prawan A; Senggunprai L; Kongpetch S; Tusskorn O; Kukongviriyapan V
    Life Sci; 2018 Aug; 207():172-183. PubMed ID: 29847773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylases and their inhibitors as potential therapeutic drugs for cholangiocarcinoma - cell line findings.
    Sriraksa R; Limpaiboon T
    Asian Pac J Cancer Prev; 2013; 14(4):2503-8. PubMed ID: 23725164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.
    Harada K; Ferdous T; Harada T; Ueyama Y
    Int J Oncol; 2016 Jul; 49(1):276-84. PubMed ID: 27210058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin inhibits tumor growth by regulating multiple miRNAs in human cholangiocarcinoma.
    Jiang X; Ma N; Wang D; Li F; He R; Li D; Zhao R; Zhou Q; Wang Y; Zhang F; Wan M; Kang P; Gao X; Cui Y
    Oncotarget; 2015 Feb; 6(5):3178-94. PubMed ID: 25605008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
    Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
    Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
    Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y
    J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway.
    Zhao W; Yang S; Chen J; Zhao J; Dong J
    Life Sci; 2018 Oct; 210():224-234. PubMed ID: 30193944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
    Duo J; Ma Y; Wang G; Han X; Zhang C
    DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma.
    Seubwai W; Wongkham C; Puapairoj A; Okada S; Wongkham S
    Cancer; 2010 Dec; 116(23):5535-43. PubMed ID: 20681031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma.
    Chen H; Zhu B; Zhao L; Liu Y; Zhao F; Feng J; Jin Y; Sun J; Geng R; Wei Y
    Cell Physiol Biochem; 2018; 47(2):641-653. PubMed ID: 29794468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status.
    Nakamura K; Nakabayashi K; Htet Aung K; Aizawa K; Hori N; Yamauchi J; Hata K; Tanoue A
    PLoS One; 2015; 10(3):e0120545. PubMed ID: 25799509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression.
    Erice O; Labiano I; Arbelaiz A; Santos-Laso A; Munoz-Garrido P; Jimenez-Agüero R; Olaizola P; Caro-Maldonado A; Martín-Martín N; Carracedo A; Lozano E; Marin JJ; O'Rourke CJ; Andersen JB; Llop J; Gómez-Vallejo V; Padro D; Martin A; Marzioni M; Adorini L; Trauner M; Bujanda L; Perugorria MJ; Banales JM
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1335-1344. PubMed ID: 28916388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells.
    Jinawath A; Akiyama Y; Sripa B; Yuasa Y
    J Cancer Res Clin Oncol; 2007 Apr; 133(4):271-8. PubMed ID: 17294242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.